Clinical trials: Why drug availability will be the next decade’s challenge
Watch the Replay/--/uploads/2025/09/LS-Featured-images.png)
Date
June 14, 2022
Location
Online event
Timing
3pm - 4pm (CEST)
9am - 10am (ET)
The evolution towards innovative drugs, like biologics or cell & gene, is marking a turning point in the clinical trial landscape. The clinical supply chain is not a support group anymore, but an active driver of the success and speed of a clinical trial.
Bottlenecks or delays in drug supply are one of the causes of delays in trial timelines and a major factor in even considering a trial feasible. As the next 10 years will worsen this issue, pharmaceutical companies will have to ensure best-in-class drug waste management to stay competitive.
In this webinar, you will learn
- What are the main trends impacting the efficiency of drug supply
- How to identify the main causes of avoidable waste in clinical trials
- What are the good practices to ensure faster recruitments and more feasible trials despite scarce drug availability
- How clinical operations, IRT, CROs, CMC and other stakeholders also have a major role to play in achieving drug waste reduction
/--/uploads/2025/09/Untitled-design-10.png)
/--/uploads/2025/09/AJE.png)
/--/uploads/2025/09/ADA-O.webp)